In 2023, Bristol Myers Squibb generated over ** billion U.S. dollars of cardiovascular drug revenue worldwide. The American company is projected to keep its leading position in this field until 2030. Cardiovascular diseases are among the most common causes of death in general. Risk for heart disease increases with diabetes, obesity, poor diet, and a lack of physical activity.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
PMLiVE. (February 9, 2026). Global leading pharmaceutical companies by cardiovascular revenue in 2023, with forecast for 2030 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 05, 2026, from /statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
PMLiVE. "Global leading pharmaceutical companies by cardiovascular revenue in 2023, with forecast for 2030 (in billion U.S. dollars)." Chart. February 9, 2026. ÌÇÐÄÆƽâ°æ. Accessed August 05, 2026. /statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
PMLiVE. (2026). Global leading pharmaceutical companies by cardiovascular revenue in 2023, with forecast for 2030 (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 05, 2026. /statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
PMLiVE. "Global Leading Pharmaceutical Companies by Cardiovascular Revenue in 2023, with Forecast for 2030 (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 9 Feb 2026, /statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
PMLiVE, Global leading pharmaceutical companies by cardiovascular revenue in 2023, with forecast for 2030 (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/ (last visited August 05, 2026)
Global leading pharmaceutical companies by cardiovascular revenue in 2023, with forecast for 2030 (in billion U.S. dollars) [Graph], PMLiVE, February 9, 2026. [Online]. Available: /statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
